Active

ENDOCRINE PHARMACEUTICALS LIMITED Financials

Company number
03005721Copy
copy info iconCopy
Registered office
Wilderness End, Tadley Common Road, Tadley, Hampshire RG26 3TA
Incorporated
04/01/1995

Company snapshot

Status
Active
Employees
3 (2025)
Latest financial data
2025
Accounts type
Total Exemption Full

Financial highlights

Latest reported figures. Okredo holds filed data for 2021–2025.

Net Assets

£-99.31K2025
-10.30%vs 2024

2024: £-90.04K

Cash in Bank

£1.52K2025
-70.68%vs 2024

2024: £5.19K

Total Liabilities

£0.002025
No changevs 2024

2024: £0.00

Employees

32025
0vs 2024

2024: 3

In 2025, ENDOCRINE PHARMACEUTICALS LIMITED reported net assets of £-99.31K. The same filing shows cash in bank of £1.52K and total liabilities of £0.00. Reported headcount was 3 in 2025. Net Assets fell from £-90.04K in 2024 to £-99.31K in 2025 (-10.30%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.

Financial performance

Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.

Net Assets

£-99.31K2025
-10.30%from £-90.04K in 2024

Year-on-year change

Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.

3-year financial trend (2023–2025)

How the figures ENDOCRINE PHARMACEUTICALS LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.

Net Assets

£-87.51K2023£-99.31K2025
Decreasedvs 2023

Cash in Bank

£2.16K2023£1.52K2025
-29.6%vs 2023

-16.1% a year compound (CAGR)

Total Liabilities

£0.002023£0.002025
No changevs 2023

Employees

3202332025
0%vs 2023

Biggest decrease

Cash in Bank-29.6%

£2.16K in 2023 to £1.52K in 2025

Every measure that changed in ENDOCRINE PHARMACEUTICALS LIMITED's filings between 2023 and 2025 fell. The steepest fall came in cash in bank, pointing to a tighter cash position, with net assets falling alongside it. Total liabilities was filed as nil in each of these years, so the direction here rests on the remaining measures. See the full year-by-year figures.

Financial history

Every indicator Okredo tracks, year by year.

Reported financial indicators for ENDOCRINE PHARMACEUTICALS LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.

Indicator20212022202320242025
Net Assets£-69.53K-77.00K-87.51K-90.04K-99.31K
Total Assets£–––––
Cash in Bank£8.88K6.60K2.16K5.19K1.52K
Total Liabilities£0.000.000.000.000.00
Employees33333

ENDOCRINE PHARMACEUTICALS LIMITED financials: frequently asked questions

Answered from this company's own filed figures.

Has ENDOCRINE PHARMACEUTICALS LIMITED filed financial statements?

toggle

Yes. Okredo holds filed figures for ENDOCRINE PHARMACEUTICALS LIMITED covering 2021–2025, across 4 reported indicators. The most recent reported year is 2025.

What net assets did ENDOCRINE PHARMACEUTICALS LIMITED report in 2025?

toggle

ENDOCRINE PHARMACEUTICALS LIMITED reported net assets of £-99.31K for 2025. That compares with £-90.04K in 2024, a change of -10.30%.

What cash in bank did ENDOCRINE PHARMACEUTICALS LIMITED report in 2025?

toggle

ENDOCRINE PHARMACEUTICALS LIMITED reported cash in bank of £1.52K for 2025. That compares with £5.19K in 2024, a change of -70.68%.

What total liabilities did ENDOCRINE PHARMACEUTICALS LIMITED report in 2025?

toggle

ENDOCRINE PHARMACEUTICALS LIMITED reported total liabilities of £0.00 for 2025. That compares with £0.00 in 2024.

How many people does ENDOCRINE PHARMACEUTICALS LIMITED employ?

toggle

ENDOCRINE PHARMACEUTICALS LIMITED reported 3 employees in 2025, compared with 3 in 2024.

How have ENDOCRINE PHARMACEUTICALS LIMITED financials changed over the last 3 years?

toggle

Between 2023 and 2025, ENDOCRINE PHARMACEUTICALS LIMITED's cash in bank fell by 29.6% and employee numbers was unchanged. Cash in bank contracted at 16.1% a year across the two years to 2025, from £2.16K to £1.52K. Reported headcount went from 3 in 2023 to 3 in 2025.

Which years of ENDOCRINE PHARMACEUTICALS LIMITED financial data are available?

toggle

Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.